New Jersey Assembly Bill A2902

New Jersey 2026-2027 Regular Session

• Introduced: 1/13/26
• Refer: 1/13/26

Caption

Expands implied consent law to include blood testing; establishes per se standard for driving under influence of marijuana and certain controlled dangerous substances.

Impact

This bill is poised to have a substantial impact on state DUI laws by instituting a 'per se' standard for driving under the influence of marijuana and specific controlled substances. Specifically, it establishes that drivers would be deemed under the influence if their blood contains three nanograms or more of THC per milliliter. This legislative change seeks to enhance the tools available to law enforcement in enforcing DUI regulations and aims to reduce incidents of impaired driving related to substance use beyond alcohol.

Summary

Assembly Bill A2902 aims to amend existing driving under the influence (DUI) laws in New Jersey by expanding the implied consent law to include blood testing. This significant change means that individuals operating a motor vehicle would be considered to have consented to blood tests for narcotics, hallucinogens, or habit-forming drugs, in addition to existing breath tests for alcohol. A refusal to submit to a blood test would carry penalties similar to those for refusing a breath test, highlighting the state's commitment to combating impaired driving.

Contention

Although the bill presents an effort to enhance road safety, it has not been without points of contention. Advocates for the bill argue it provides necessary updates to current laws to make them more applicable in a context where marijuana usage, particularly following legalization, is prevalent. Critics, however, express concerns over the implications for personal rights and argue that laws must also consider the social and physiological complexities of drug influences on driving ability. This raises questions about the fairness and accuracy of the testing standards proposed by the bill.